190 filings
Page 7 of 10
8-K
erprxu7tgdzs8 mwe8
21 May 19
Entry into a Material Definitive Agreement
4:39pm
424B4
a9pedhoz
17 May 19
Prospectus supplement with pricing info
5:01pm
424B4
i1k1pycdacp1hbbs8kf4
15 May 19
Prospectus supplement with pricing info
4:47pm
8-K
h6dva
8 May 19
Regulation FD Disclosure
8:50am
8-K
9tjve
30 Apr 19
Evolus Reports First Quarter 2019 Financial Results
4:03pm
DEFA14A
khhaei bfx
29 Apr 19
Additional proxy soliciting materials
5:08pm
DEF 14A
8vwut 6vi8ie7g7ez
29 Apr 19
Definitive proxy
5:06pm
8-K
ol7pz39qk8tgi50
26 Apr 19
Evolus Receives Positive CHMP Opinion for Nuceiva™ in the European Union
9:01am
EFFECT
m1lc wyvi
16 Apr 19
Notice of effectiveness
12:15am
CORRESP
awlph ah5tbj68
11 Apr 19
Correspondence with SEC
12:00am
S-3/A
v24b6 0od
10 Apr 19
Shelf registration (amended)
6:33am
CORRESP
2xwfxn
10 Apr 19
Correspondence with SEC
12:00am
UPLOAD
dhpw 0sqd
4 Apr 19
Letter from SEC
12:00am
8-K
lsj1fi3zutkrhet7
1 Apr 19
Evolus Provides Regulatory Update on Nuceiva™ in the European Union
9:05am
S-3
3ecszl1
22 Mar 19
Shelf registration
4:56pm
8-K
10m9sy 3yysnr
18 Mar 19
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
4:05pm
S-8
tzdkki0fvbjew
10 Jan 19
Registration of securities for employees
4:06pm
8-K
549l0hf
4 Jan 19
Regulation FD Disclosure
12:00am